There are 2867 resources available
935P - Demographics, clinical characteristics, treatment patterns and clinical outcomes of patients with stages I-III resected NSCLC without known EGFR mutations
Presenter: Nasser Altorki
Session: Poster session 04
936P - Analysis of different EGFR mutations affecting the efficacy of postoperative adjuvant therapy for resectable non-small cell lung cancer
Presenter: Chuan Xu
Session: Poster session 04
937P - Incidence and outcomes of EGFR mutated non-small cell lung cancer treated with surgery: EXERPOS GFPC study
Presenter: Jean Bernard Auliac
Session: Poster session 04
939P - Changes in immune gene signatures after neoadjuvant chemoimmunotherapy treatment in NSCLC patients from NADIM trial
Presenter: Marta Casarrubios
Session: Poster session 04
940P - Programmed death-ligand 1 (PDL1) expression and real-world outcomes in resected, early-stage non-small cell lung cancer (NSCLC)
Presenter: Parneet Cheema
Session: Poster session 04
941P - PET-derived parameters for response assessment in neoadjuvant atezolizumab: A secondary analysis of PRINCEPS phase II trial
Presenter: Filippo Dall'Olio
Session: Poster session 04
942P - Camrelizumab combined with albumin paclitaxel and platinum in perioperative treatment of resectable squamous cell lung cancer: A single-arm, open-label, phase II clinical trial
Presenter: Yushan Zhang
Session: Poster session 04
943P - Association between event-free survival and overall survival following neoadjuvant therapy for non-small-cell lung cancer
Presenter: Gyula Ostoros
Session: Poster session 04
944P - Hazard function analysis of recurrence in patients with curatively resected lung cancer: Results from the Japanese Lung Cancer Registry in 2010
Presenter: Yoshikane Yamauchi
Session: Poster session 04
945P - Respiratory and cardiometabolic comorbidities and stage I-III non-small cell lung cancer (NSCLC) survival: A pooled analysis from the International Lung Cancer Consortium (ILCCO)
Presenter: Miguel García Pardo de Santayana
Session: Poster session 04